ADDED
paii-20250930 http://fasb.org/srt/2025#ChiefFinancialOfficerMember 00-0000000 0002069238 false Q3 --12-31 This number includes an aggregate of up to 946,428 Class B shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters.
All share and per share data have been retroactively applied.
All share and per share data have been retroactively applied.
All share and per share data have been retroactively applied.
All share and per share data have been retroactively applied.
II Notes to Unaudited Condensed Financial Statements September 30, 2025 NOTE 1 ORGANIZATION AND BUSINESS OPERATIONS Pyrophyte Acquisition Corp.
II (the Company ) is a blank check company incorporated as a Cayman Islands exempted company on May 1, 2025 .
As of September 30, 2025, the Company had not yet commenced operations.
Liquidity and Capital Resources As of September 30, 2025, the Company had a cash balance of $ 721,227 and due from Sponsor balance of $ 353,445 .
The Company had $ 721,227 in cash and no cash equivalents as of September 30, 2025.
REMOVED
UNAUDITED CONDENSED FINANCIAL STATEMENTS Unaudited Condensed Balance Sheet as of June 30, 2025 (unaudited) 1 Unaudited Condensed Statement of Operations for the period from May 1, 2025 (Inception) through June 30, 2025 2 Unaudited Condensed Statement of Changes in Shareholders Deficit for the period from May 1, 2025 (Inception) through June 30, 2025 3 Unaudited Condensed Statement of Cash Flows for the period from May 1, 2025 (Inception) through June 30, 2025 4 Notes to Unaudited Condensed Financial Statements 5 Item 2.
II Notes to Unaudited Condensed Financial Statements NOTE 1 ORGANIZATION AND BUSINESS OPERATIONS Pyrophyte Acquisition Corp.
II (the Company ) is a blank check company incorporated as a Cayman Islands exempted company on May 1, 2025.
As of June 30, 2025, the Company had not yet commenced operations.
Liquidity and Capital Resources As of June 30, 2025, the Company had a cash balance of $ 0 .
The Company did not have any cash equivalents as of June 30, 2025.
Fair Value Instruments The fair value of the Company s assets and liabilities, which qualify as financial instruments under the FASB ASC 820, Fair Value Measurement, approximates the carrying amounts represented in the balance sheet, primarily due to their short-term nature.
Deferred offering costs consist principally of professional and registration fees that are related to the initial public offering.
On July 18, 2025, in connection with the Company s IPO, offering costs allocated to the Class A ordinary shares were charged to temporary equity and offering costs allocated to the public and private placement warrants were charged to shareholders equity (deficit) as public and private placement warrants, after management s evaluation, are accounted for under equity treatment.
As of June 30, 2025, the Company had deferred offering costs of $ 217,104 .